Browsing: Tavneos

A drug used to treat rare autoimmune diseases has been recalled from shelves in the Republic of Ireland

The pressure on Amgen’s Tavneos is ratcheting up ahead of a potential hearing about the future of the drug. Since the FDA proposed withdrawing approval in April, a journal has retracted a key paper on the rare disease drug, the European Medicines Agency has recommended revoking authorization and Amgen’s Japanese partner has reportedly urged doctors…